Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Basilea Pharmaceutica"
Count: 67
Selected: 0
| NCT ID | Title |
|---|
| NCT02895360 | Phase 1/2a Study of BAL101553 as 48-hour Infusions in Patients With Advanced Solid Tumors or Recurrent Glioblastoma | ||
| NCT04604132 | Derazantinib Alone or in Combination With Paclitaxel, Ramucirumab or Atezolizumab in Gastric Adenocarcinoma | ||
| NCT03138733 | Ceftobiprole in the Treatment of Patients With Staphylococcus Aureus Bacteremia | ||
| NCT03230318 | Derazantinib in Subjects With FGFR2 Gene Fusion-, Mutation- or Amplification- Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma | ||
| NCT04045613 | Derazantinib and Atezolizumab in Patients With Urothelial Cancer | ||
| NCT02490800 | Phase 1/2a Study of Oral BAL101553 in Adult Patients With Solid Tumors or Glioblastoma or High-grade Glioma | ||
| NCT04087876 | Expanded Access Use of Derazantinib for Advanced Intrahepatic Cholangiocarcinoma (iCCA) With FGFR Genomic Alterations | ||
| NCT04098692 | Mass Balance and Pharmacokinetics Study of Derazantinib in Healthy Male Subjects | ||
| NCT02527681 | Pharmacokinetics and Safety of Ceftobiprole in Neonates and Infants up to 3 Months Treated With Systemic Antibiotics | ||
| NCT03137173 | Ceftobiprole in the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infections | ||
| NCT03439124 | Ceftobiprole in the Treatment of Pediatric Patients With Pneumonia | ||
| NCT03250299 | Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma | ||
| NCT01397929 | An Open-Label Study of Intravenous BAL101553 in Adult Patients With Solid Tumors | ||
| NCT01752920 | Phase 1/2 Study of Derazantinib (ARQ 087) in Adult Subjects With Advanced Solid Tumors With FGFR Genetic Alterations | ||
| NCT00413439 | Safety, Efficacy and Pharmacokinetics of an Antifungal in Patients Undergoing Chemotherapy | ||
| NCT00505258 | Ceftobiprole in the Treatment of Hospitalized Patients With Staphylococcus Aureus Bacteremia | ||
| NCT00229008 | Ceftobiprole in Hospital Acquired Pneumonia | ||
| NCT00210964 | Ceftobiprole in Hospital Acquired Pneumonia | ||
| NCT01030731 | Pharmacokinetic Study,Ceftobiprole,Healthy Volunteers,Healthy Patients With End Stage Renal Disease | ||
| NCT01026558 | A Study Evaluating the Pharmacokinetics of Ceftobiprole When Taken by Obese Patients | ||
| NCT00326287 | Ceftobiprole in the Treatment of Patients With Community-Acquired Pneumonia | ||
| NCT00529282 | A Study of Ceftobiprole in Patients With Fever and Neutropenia. | ||
| NCT01026740 | Evaluation of Penetration of Ceftobiprole Into Soft Tissue Determined by Microdialysis in Healthy Volunteers | ||
| NCT00965042 | Effect of Ceftobiprole on Human Intestinal Microflora | ||
| NCT00771719 | Open Label Pharmacokinetic in Adult Patients With Ventilator-Associated Pneumonia | ||
| NCT00771524 | Pharmacokinetic Study of the Penetration of Ceftobiprole in the Bone | ||
| NCT00770978 | Open Label Study of Ceftobiprole to Evaluate Pharmacokinetics in Adults Hospitalized in the ICU | ||
| NCT01026636 | A Single-Dose Pharmacokinetics and Safety Study of Ceftobiprole in Pediatric Patients =3 Months to <18 Years of Age | ||
| NCT00228982 | Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections | ||
| NCT00210899 | Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections | ||
| NCT00519675 | Alitretinoin in the Treatment of Chronic Hand Eczema | ||
| NCT00309621 | Safety and Efficacy of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis | ||
| NCT00124475 | Efficacy and Safety of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis | ||
| NCT00124436 | Follow-up Efficacy and Safety of Alitretinoin in Severe Chronic Hand Dermatitis | ||
| NCT00817063 | Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema | ||
| NCT00413218 | Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections | ||
| NCT01245140 | Efficacy of Alitretinoin Treatment in Patients With Pustular Form of Psoriasis | ||
| NCT01406171 | Drug Interaction Study of Isavuconazole and Midazolam | ||
| NCT03241550 | A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients | ||
| NCT00412893 | Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis | ||
| NCT00634049 | Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi | ||
| NCT01407679 | Efficacy and Safety of Oral Alitretinoin (Toctino®) in the Treatment of Patients With Cutaneous Lupus Erythematosus | ||
| NCT01657890 | Study of the Pharmacokinetics of Isavuconazole in Healthy Non-Elderly and Elderly Male and Female Subjects | ||
| NCT01657838 | Drug Interaction Study of the Effect of Ketoconazole at Steady State on the Pharmacokinetics of a Single Dose of Isavuconazole in Healthy Adult Subjects | ||
| NCT01635972 | Drug Interaction Study of Multiple Doses of Isavuconazole and a Single Dose of Bupropion | ||
| NCT01582412 | Drug Interaction Study of Isavuconazole and Digoxin | ||
| NCT01555866 | Study of the Effect of Renal Impairment on the Pharmacokinetics of Isavuconazole. | ||
| NCT01660477 | Drug-drug Interaction Study Between Lopinavir/Ritonavir and Isavuconazole | ||
| NCT01651325 | Drug Interaction Study of Multiple Doses of Isavuconazole and Single Dose of Dextromethorphan in Healthy Adult Subjects | ||
| NCT01635946 | Drug Interaction Study of Multiple Doses of Isavuconazole and Single Dose of Atorvastatin |
